Physiotherapy in conservatively managed distal radius fractures
- Conditions
- Topic: Musculoskeletal disordersDisease: MusculoskeletalSubtopic: Musculoskeletal (all Subtopics)Musculoskeletal DiseasesDistal radial fracture
- Registration Number
- ISRCTN62731680
- Lead Sponsor
- ottingham University Hospitals NHS Trust
- Brief Summary
2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33926211/ (added 13/05/2022)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 120
1. Aged between 18 and 70 years at the time of fracture
2. Able to give informed consent
3. Any fracture of the distal radius within 3cm of the radiocarpal joint will be considered for inclusion (including intraarticular fractures, fractures with comminution, associated ulnar styloid fracture, dorsal and volar displacement patterns) provided it has been deemed suitable for conservative management by the treating physician.
4. Fracture treated with immobilisation (plaster of paris / fibreglass cast / splint) worn constantly for between 5 and 7 weeks
5. English should be the patient's first language
1. A fracture which extends beyond 3 cm of the radiocarpal joint
2. Any patient with bilateral fractures
3. A fracture which has been immobilised outside of the range of 5 and 7 weeks
4. Any patient who is deemed to be unlikely to be able to adhere to the trial procedure or complete the questionnaires (e.g. drug dependence or cognitive impairment)
5. Current participation in another ongoing study
6. Evidence of complex regional pain syndrome
7. Post plaster stiffness of the fingers which prevents the patient from being able to place their hand flat on a tabletop
8. Any previous fracture of the wrist or carpal bones whether treated operatively or conservatively
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptoms and ability in the affected arm are measured using the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire at baseline, 6 , 12 and 52 weeks.
- Secondary Outcome Measures
Name Time Method <br> 1. EQ5D at baseline, 6 , 12 and 52 weeks<br> 2. Patient Evaluation Measure (PEM) at baseline, 6, 12 and 52 weeks<br> 3. Routine Outcome Measures (ROM) at 6, 12 and 52 weeks<br>